Publication | Closed Access

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Relapsing-remitting Multiple SclerosisMri-monitored Disease ActivityNeurological DisorderMedicineNeurological ProgressNeuroimagingRehabilitationNeurologyMultiple SclerosisNeurorehabilitationNeuroimmunology